Funds and ETFs Sam Chun Dang Pharm. Co., Ltd

Equities

A000250

KR7000250001

Pharmaceuticals

End-of-day quote Korea S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
104,600 KRW -0.95% Intraday chart for Sam Chun Dang Pharm. Co., Ltd +4.39% +35.32%

ETFs positioned on Sam Chun Dang Pharm. Co., Ltd

SAM CHUN DANG PHARM. CO., LTD is a Korea-based company mainly engaged in the manufacture of prescription medicines. The Company’s products portfolio consists of antibiotics used for treatment of sepsis, respiratory diseases and others; circulatory disease medicines including cardiovascular and endocrine medicaments used for treatment of diabetes, hypertension, angina and others under the brand names of Glilazide and Atenolol; digestive medicines used for treatment of duodenal ulcer, gastritis and others; ophthalmological agents used for treatment of conjunctivitis, keratitis and other eye inflammation under the brand names of Ofus and Toracin, and anti-inflammatories used to release postoperative pains under the brand name Barotase and others.
More about the company
  1. Stock Market
  2. Equities
  3. A000250 Stock
  4. Funds and ETFs Sam Chun Dang Pharm. Co., Ltd